New study aims to decode how cancer survivors talk about fatigue

NCT ID NCT06634381

Recruiting now Knowledge-focused Sponsor: Wake Forest University Health Sciences Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 24, 2026 · Updated 2 times

Summary

This study looks at how cancer survivors describe their fatigue, a common and often misunderstood symptom. Researchers will interview 80 survivors and their doctors to find common themes and language. The goal is to create a visual aid (like a Venn diagram) to help patients and providers discuss fatigue more effectively. This is a knowledge-gathering study, not a treatment trial.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could lead to a simple visual tool that helps cancer survivors and their doctors talk about fatigue more clearly, potentially improving symptom management.
What could go wrong: This is a small, early-stage pilot study (80 participants) focused on understanding language, not testing a treatment. The visual aid may not be widely useful or may not improve outcomes in practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer Fatigue neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER FATIGUE

Contacts and locations

Locations

Levine Cancer Institute
RECRUITING

Charlotte, North Carolina, 28204, United States
Levine Childrens Hospital Pediatric Cancer and Blood Disorders
RECRUITING

Charlotte, North Carolina, 28203, United States
Wake Forest Baptist Comprehensive Cancer Center
RECRUITING

Winston-Salem, North Carolina, 27157, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.